Consent forms for SACT (Systemic Anti-Cancer Therapy)
WEB4 days ago · Find national standardised SACT regimen-specific consent forms for different tumour sites, endorsed by the UK Systemic Anti-Cancer Therapy Board. Download PDF forms, check review dates, and get FAQs on electronic consent and new regimens.
Novartis Patient Support | KISQALI® (ribociclib) | HCP
WEBFill out all required sections with the patient. Ensure both you and the patient sign to capture consent; Fax completed form to Novartis Patient Support at 1-800-414-3518; Missing information may result in delays. Novartis Patient Support will contact you to request any incomplete information
Download Helpful Patient Resources | KISQALI® (ribociclib)
WEBDownload helpful patient resource materials about metastatic breast cancer and KISQALI ® (ribociclib) treatment. See full Prescribing & Safety Information.
Downloadable Resources | KISQALI® (ribociclib) | HCP
WEBAccess resource materials for health care professionals about 1L HR+/HER2- metastatic breast cancer and KISQALI treatment. See full Prescribing & Safety Info.
WEBElectrocardiogram (ECG) Testing Support Only: Check this box and complete all required fields below if you would like to enroll your patient in ECG testing support only (and no other services). Please fill out all fields on this form to enroll in Novartis Patient Support. 1.
Ribociclib (Kisqali®) + Fulvestrant (Faslodex®) - ChemoExperts
WEBA consent form contains information about your treatment, including possible risks and expected benefits. Signing the consent means that you understand and agree that the possible benefits outweigh risks and that you are willing to move forward with treatment.
WEBWhat is KISQALI? KISQALI is a prescription medicine used to treat adults with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer that has gotten worse or has spread to other parts of the body (metastatic), in combination with: • an aromatase inhibitor as the first endocrine-based therapy; or.
Savings and Support | KISQALI
WEBLearn how to get personalized support, financial assistance, and insurance help for KISQALI, a treatment for metastatic breast cancer. Find out about Co-Pay Plus, Bridge Program, and Free Trial Offer options.
WEBRibociclib. This information from Lexicomp explains what you need to know about this medication, including what it’s used for, how to take it, its side effects, and when to call your healthcare provider.
Ribociclib (Kisqali) | FDA - U.S. Food and Drug Administration
WEBRibociclib is a cyclin-dependent kinase 4/6 inhibitor that is used in combination with an aromatase inhibitor for postmenopausal women with hormone receptor-positive, HER2-negative advanced or...